Nuclear Track Detectors for Environmental Studies and Radiation Monitoring

Several improvements were made for Nuclear Track Detectors (NTDs) used for environmental studies and for particle searches. A new method was used to determine the bulk etch rate of CR39 and Makrofol NTDs. It is based on the simultaneous measurement of the diameter and of the height of etch-pit cones caused by relativistic heavy ions (158 A GeV Pb(82+) and In(49+) ions) and their fragments. The use of alcohol in the etching solution improves the surface quality of NTDs and it raises their thresholds. The detectors were used for the determination of nuclear fragmentation cross sections of Iron and Silicon ions of 1.0 and 0.41 GeV/nucleon. These measurements are important for the determination of doses in hadron therapy and for doses received by astronauts. The detectors were also used in the search of massive particles in the cosmic radiation, for the determination of the mass spectrum of cosmic rays and for the evaluation of Po(210) alpha decay and of natural radon concentrations.Comment: 7 pages, 5 EPS figures. Presented at the 10th Topical Seminar on Innovative Particle and Radiation Detectors, 1-5 October 2006, Siena, Ital

Search for possible neutrino radiative decays during the 2001 total solar eclipse

We present the results of the observations performed in the occasion of the June 21, 2001 total solar eclipse, looking for visible photons emitted trough a possible radiative decay of solar neutrinos. We establish lower limits for the neutrino proper lifetimes larger than 1000 s/eV, for neutrino masses larger than 0.01 eV.Comment: 18 pages, 11 figures, accepted by Astopart. Phys, updated reference

The surgical management of locally advanced well-differentiated thyroid carcinoma. Changes over the years according to the AJCC 8th edition Cancer Staging Manual

Background: Well-differentiated thyroid carcinoma is defined as locally advanced in the presence of an extra thyroid extension, e.g., when the surrounding structures such as the trachea, larynx, esophagus and main blood vessels are invaded by cancer. The 8th edition AJCC Cancer Staging Manual states that this is the main characteristic to evaluate for the staging and consequently for the prognosis in patients over 55 years old. Main body: Distinguishing different forms of locally advanced thyroid cancer is essential, and the various anatomical structures and the clinical and therapeutic consequences must be taken into account. An accurate diagnosis of the organs invaded by thyroid cancer is necessary for the planning of surgical treatment, and both aspects are crucial to improving the patients' survival. Patients affected by thyroid cancer with extra thyroid extension have a poor prognosis and the removal of the entire neoplasm represents a key factor for better disease-free survival. Conclusions: We discuss the changes introduced by the 8th edition AJCC Cancer Staging Manual, in terms of the diagnostic and surgical management of extra thyroid extension, in patients affected by papillary and follicular thyroid cancer

Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat

In this paper we report a case of iatrogenic Cushing syndrome due to a pharmacological interaction between fluticasone and cobicistat. Inhaled corticosteroids were previously thought to be safe, but increasing numbers of cases of iatrogenic Cushing syndrome are being reported, especially in patients taking cytochrome P450 inhibitors, including cobicistat. Although the drug interaction between cobicistat and fluticasone has been described elsewhere, to our knowledge we present one of the first descriptions of iatrogenic Cushing syndrome due to this pharmacological interaction

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study

To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months. To further evaluate the rate of patients maintaining the remission and the rate of CCSs discontinuation, after additional 12 months of follow-up.A retrospective evaluation of patients prospectively followed was designed to compare the rate of clinical remission in naïve AOSD patients treated with high dosages of CCSs (0.8-1 mg/kg/day of prednisone-equivalent) or low dosage of CCSs (0.2-0.3 mg/kg/day of prednisone-equivalent), after 6 months. An additional analysis was performed to compare the rate of monocyclic pattern between these groups, after further 12 months of follow-up.The clinical remission was achieved in a higher percentage of patients treated with the first-line treatment with high dosage of CCSs than treated the first-line treatment with low dosage of CCSs. At the end of 18 months of follow-up, a larger percentage of patients treated the first-line treatment with high dosage of CCSs was classified as monocyclic pattern and discontinued CCSs when compared with patients treated the first-line treatment with low dosage of CCSs. Patients defined as CCSs non-responder were treated with methotrexate (MTX)+CCSs or with combination therapy CCSs+MTX+biologic drug. The clinical remission was observed in a percentage of these patients.We showed the effectiveness of the first-line treatment with high dosage of CCSs in inducing clinical remission in naïve AOSD patients when compared with the first-line treatment with low dosage of CCSs. The first-line treatment with high dosage of CCSs was also associated with the achievement of monocyclic pattern and CCSs discontinuation, after 18 months of follow-up